HLCS and breast cancer: We have previously shown that suppression of HLCS expression lowers biotinylation of carboxylases accompanied by impaired growth, migration and invasion, and cell cycle arrest in both luminal subtype (MCF-7) and triple-negative subtype (MDA-MB-231) breast cancer cell lines (Siritutsoontorn et al., 2022).